Volume 31, Supplement—May 2025
SUPPLEMENT ISSUE
Supplement
16S Ribosomal RNA Gene PCR and Sequencing for Pediatric Infection Diagnosis, United States, 2020–2023
Table 3
Microorganisms detected by 16S rRNA PCR and sequencing and associated specimen sources from a study of 16S ribosomal RNA gene PCR and sequencing for pediatric infection diagnosis, Mayo Clinic, Rochester, Minnesota, USA, 2020–2023
Identified bacteria | No. (%) positive results, n = 33 | Specimen source (no. tests) |
---|---|---|
Polymicrobial | 12 (36) | Bone tissue (4*), subdural fluid (3*), cerebrospinal fluid (1), peri-implant tissue (1), vitreous fluid (1*), synovial tissue (1), peritoneal fluid (1*) |
Staphylococcus aureus complex | 4 (12) | Synovial fluid (4) |
Kingella kingae | 3 (9) | Synovial fluid (3*) |
Streptococcus mitis group | 3 (9) | Pleural fluid (1), pleural fluid (2*) |
Fusobacterium naviforme/nucleatum | 2 (6) | Synovial fluid (1*), CSF (1*) |
Streptococcus intermedius | 2 (6) | Cerebrospinal fluid (2) |
Cardiobacterium hominis | 1 (3) | Peri-implant tissue (1*) |
Enterococcus faecalis | 1 (3) | Heart valve tissue (1) |
Fusobacterium necrophorum | 1 (3) | Pleural fluid (1) |
Pseudomonas aeruginosa | 1 (3) | Synovial tissue (1*) |
Staphylococcus epidermidis | 1 (3) | Cerebrospinal fluid (1) |
Streptococcus dysgalactiae | 1 (3) | Synovial fluid (1*) |
Streptococcus pyogenes | 1 (3) | Pleural fluid (1*) |
*Specimens with negative bacterial cultures from the same specimen source.
Page created: April 11, 2025
Page updated: May 13, 2025
Page reviewed: May 13, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.